Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Acad Nutr Diet. 2012 Aug;112(8):1147–1157. doi: 10.1016/j.jand.2012.05.008

Table 2.

Time-specific physiologic outcomes, and within- and between- treatment group mean differences over time (i.e., baseline-3 months and baseline-6 months) in ENHANCE Study participants

Physiologic Outcome Time-specific outcomes Within and between treatment group differences over time
Within group change from baselinec Between group change from baselined
Technology Supported Behavioral Intervention (n=131a) Attention Control (n=132a) p-valueb Time Interval Technology Supported Behavioral Intervention (n=131a) Attention Control (n=132a) DiffINT-DiffControl
Mean SD Mean SD DiffINT SD DiffControl SD Mean 95% CI p-value
A1c (%) Baseline 7.7 2.2 7.5 1.7 0.49
3m 7.1 1.5 7.2 1.5 0.94 Base-3m 0.5*** 1.5 0.3*** 0.9 0.2 -0.1 0.5 0.26
6m 7.1 1.3 7.3 1.6 0.31 Base-6m 0.6*** 1.8 0.2* 1.3 0.4 0.01 0.8 0.046
Fasting Serum Glucose (mg/dl) Baseline 145.3 58.1 143.1 58.1 0.78
3m 131.4 47.9 136.2 49.7 0.43 Base-3m 14.7** 52.7 6.4 46.4 8.3 -4.2 20.7 0.20
6m 132.6 49.1 135.2 52.1 0.69 Base-6m 13.2* 61.0 8.0* 44.9 5.2 -8.7 19.0 0.46
Fasting LDL (mg/dl) Baseline 107.4 40.7 108.6 34.3 0.81
3m 104.2 37.4 108.5 37.1 0.37 Base-3m 5.0 33.9 -0.03 28.8 5.0 -3.3 13.3 0.23
6m 102.1 32.1 106.7 37.4 0.34 Base-6m 3.5 27.1 0.4 30.5 3.0 -4.7 10.8 0.44
Fasting HDL (mg/dl) Baseline 49.0 15.4 46.1 13.5 0.11
3m 48.2 15.0 46.8 13.5 0.43 Base-3m 0.8 7.7 -0.4 9.4 1.3 -0.9 3.4 0.26
6m 50.0 15.4 46.6 13.8 0.08 Base-6m -1.1 9.2 -0.3 9.1 -0.7 -3.0 1.6 0.54
Fasting Triglycerides (mg/dl) Baseline 155.0 111.6 153.7 91.7 0.92
3m 142.7 81.9 149.5 79.7 0.50 Base-3m 14.9* 83.7 1.7 60.7 13.2 -4.8 31.2 0.15
6m 143.7 101.8 149.4 89.5 0.64 Base-6m 6.3 78.8 4.4 69.2 2.0 -16.9 20.8 0.84
Systolic BP (mmHg) Baseline 135.2 18.7 138.7 18.9 0.14
3m 133.2 20.9 136.0 19.1 0.26 Base-3m 2.1 17.0 3.2+ 18.7 -1.2 -5.5 3.2 0.60
6m 134.2 19.0 136.8 20.1 0.29 Base-6m 0.8 19.9 2.4 21.7 -1.7 -7.0 3.7 0.54
Diastolic BP (mmHg) Baseline 75.6 9.8 75.8 10.0 0.83
3m 73.4 9.8 74.1 9.7 0.55 Base-3m 2.1** 8.6 1.5 10.1 0.7 -1.6 2.9 0.56
6m 74.0 10.1 74.5 10.6 0.73 Base-6m 1.2 10.8 1.2 10.9 -0.004 -2.8 2.8 0.99
Weight (kg) Baseline 95.1 21.7 98.3 21.5 0.24
3m 93.7 20.4 97.7 21.6 0.12 Base-3m 0.9** 3.4 0.7** 2.7 0.2 -0.5 1.0 0.54
6m 94.3 22.7 97.3 21.3 0.26 Base-6m 0.6 4.6 0.8* 3.8 -0.1 -1.2 0.9 0.78
Body Mass Index (kg/m2) Baseline 34.0 7.3 35.1 7.7 0.21
3m 33.4 6.7 34.9 7.7 0.11 Base-3m 0.3** 1.2 0.3** 1.0 0.1 -0.2 0.3 0.61
6m 33.5 7.6 34.8 7.5 0.21 Base-6m 0.2 1.5 0.3* 1.4 -0.1 -0.4 0.3 0.73
Waist Circumference (in) Baseline 43.6 5.8 44.8 6.9 0.12
3m 43.3 5.7 44.4 7.6 0.20 Base-3m 0.2 2.7 0.04 2.8 0.2 -0.5 0.9 0.62
6m 42.9 5.8 44.3 6.1 0.07 Base-6m 0.5 2.8 0.5 3.3 -0.03 -0.8 0.8 0.94
+

p=0.05

*

p<0.05

**

p<0.01

***

p<0.001

a

Assessments at 3 months are missing for 3 Technology Supported Behavioral Intervention and 4 Attention Control Group participants; Assessments at 6 months are missing for 11 Technology Supported Behavioral Intervention and 6 Attention Control Group participants. Other intermittent missing data are rare, except for 8.4% missing waist circumference in the Technology Supported Behavioral Intervention.

b

Two sample t-tests with bootstrap standard errors

c

One sample t-tests of difference scores with bootstrap standard errors

d

Two sample t-tests of difference scores with bootstrap standard errors